Skip to content

Study · Case report or series · 1982

1 result

Robinow's syndrome. Partial primary hypogonadism in pubertal boys, with persistence of micropenis.

Lee PA, Migeon CJ, Brown TR, Robinow M

American journal of diseases of children (1960)1 Apr 1982Cited by 6 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesOther

    In postpubertal male patients with Robinow's syndrome, serum luteinizing hormone showed a hyperresponse to gonadorelin hydrochloride stimulation.

    In plain wordsIn older boys and men with Robinow's syndrome, luteinizing hormone rose more than expected after a gonadorelin test dose.

    Outcome
    IncreaseSerum LH response to gonadorelin stimulation
    Study

    n: not reported in source

    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    a hyperresponse of serum luteinizing hormone to gonadorelin hydrochloride (Factrel) stimulation among postpubertal male patients
    1 context sentence
    Summary · context
    We studied four patients with Robinow's syndrome.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.